Global Clinical Trial Management System (CTMS) Market 2020-2024

臨床試験管理システム(CTMS)の世界市場2020-2024

◆タイトル:Global Clinical Trial Management System (CTMS) Market 2020-2024
◆商品コード:IRTNTR43269
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2020年4月20日
◆ページ数:120
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥265,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥318,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥424,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートでは臨床試験管理システム(CTMS)の世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、エンドユーザー別(製薬及びバイオテクノロジー企業、CRO、その他)分析、顧客状況、地域別状況、企業状況、企業分析などの情報をお届けいたします。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・臨床試験管理システム(CTMS)の世界市場:エンドユーザー別(製薬及びバイオテクノロジー企業、CRO、その他)
・顧客状況
・地域別状況
・企業状況
・企業分析

Global Clinical Trial Management System Market 2020-2024

Technavio has been monitoring the clinical trial management system market and it is poised to grow by $ 504.00 million during 2020-2024 progressing at a CAGR of 11% during the forecast period. Our reports on clinical trial management system market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing outsourcing of clinical trial process.

The clinical trial management system market analysis includes end-user segment and geographic landscapes
Technavio’s clinical trial management system market is segmented as below:
By End-user
• Pharmaceutical and biotechnology companies
• CROs
• other

By Geographic landscapes
• North America
• Europe
• Asia
• ROW

This study identifies the increasing healthcare expenditure as one of the prime reasons driving the clinical trial management system market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our clinical trial management system market covers the following areas:

• Clinical trial management system market sizing
• Clinical trial management system market forecast
• Clinical trial management system market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading clinical trial management system market vendors that include ArisGlobal LLC, Bioclinica, Bio-Optronics Inc., Dassault Systemes SE, DATATRAK International Inc., International Business Machines Corp., Medpace Holdings Inc., Oracle Corp., Parexel International Corp., and Veeva Systems Inc.. Also, the clinical trial management system market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/global-clinical-trial-management-system-ctms-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【資料の目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five Force Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by End-user
o Market segments
o Comparison by End-user
o Pharmaceutical and biotechnology companies – Market size and forecast 2019-2024
o CROs – Market size and forecast 2019-2024
o Others – Market size and forecast 2019-2024
o Market opportunity by End user
• Customer Landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o Asia – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Volume driver – demand-led growth
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
o Competitive scenario
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o ArisGlobal LLC
o Bioclinica
o Bio-Optronics Inc.
o Dassault Systemes SE
o DATATRAK International Inc.
o International Business Machines Corp.
o Medpace Holdings Inc.
o Oracle Corp.
o Parexel International Corp.
o Veeva Systems Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: End user – Market share 2019-2024 (%)
• 22: Comparison by End user
• 23: Pharmaceutical and biotechnology companies – Market size and forecast 2019-2024 ($ million)
• 24: Pharmaceutical and biotechnology companies – Year-over-year growth 2019-2024 (%)
• 25: CROs – Market size and forecast 2019-2024 ($ million)
• 26: CROs – Year-over-year growth 2019-2024 (%)
• 27: Others – Market size and forecast 2019-2024 ($ million)
• 28: Others – Year-over-year growth 2019-2024 (%)
• 29: Market opportunity by End user
• 30: Customer landscape
• 31: Market share by geography 2019-2024 (%)
• 32: Geographic comparison
• 33: North America – Market size and forecast 2019-2024 ($ million)
• 34: North America – Year-over-year growth 2019-2024 (%)
• 35: Europe – Market size and forecast 2019-2024 ($ million)
• 36: Europe – Year-over-year growth 2019-2024 (%)
• 37: Asia – Market size and forecast 2019-2024 ($ million)
• 38: Asia – Year-over-year growth 2019-2024 (%)
• 39: ROW – Market size and forecast 2019-2024 ($ million)
• 40: ROW – Year-over-year growth 2019-2024 (%)
• 41: Key leading countries
• 42: Market opportunity by geography ($ million)
• 43: Impact of drivers and challenges
• 44: Vendor landscape
• 45: Landscape disruption
• 46: Industry risks
• 47: Vendors covered
• 48: Market positioning of vendors
• 49: ArisGlobal LLC – Overview
• 50: ArisGlobal LLC – Product and service
• 51: ArisGlobal LLC – Key offerings
• 52: ArisGlobal LLC – Key customers
• 53: ArisGlobal LLC – Segment focus
• 54: Bioclinica – Overview
• 55: Bioclinica – Product and service
• 56: Bioclinica – Key offerings
• 57: Bioclinica – Key customers
• 58: Bioclinica – Segment focus
• 59: Bio-Optronics Inc. – Overview
• 60: Bio-Optronics Inc. – Product and service
• 61: Bio-Optronics Inc. – Key offerings
• 62: Bio-Optronics Inc. – Key customers
• 63: Bio-Optronics Inc. – Segment focus
• 64: Dassault Systemes SE – Overview
• 65: Dassault Systemes SE – Business segments
• 66: Dassault Systemes SE – Key offerings
• 67: Dassault Systemes SE – Key customers
• 68: Dassault Systemes SE – Segment focus
• 69: DATATRAK International Inc. – Overview
• 70: DATATRAK International Inc. – Product and service
• 71: DATATRAK International Inc. – Key offerings
• 72: DATATRAK International Inc. – Key customers
• 73: DATATRAK International Inc. – Segment focus
• 74: International Business Machines Corp. – Overview
• 75: International Business Machines Corp. – Business segments
• 76: International Business Machines Corp. – Key offerings
• 77: International Business Machines Corp. – Key customers
• 78: International Business Machines Corp. – Segment focus
• 79: Medpace Holdings Inc. – Overview
• 80: Medpace Holdings Inc. – Business segments
• 81: Medpace Holdings Inc. – Key offerings
• 82: Medpace Holdings Inc. – Key customers
• 83: Medpace Holdings Inc. – Segment focus
• 84: Oracle Corp. – Overview
• 85: Oracle Corp. – Business segments
• 86: Oracle Corp. – Key offerings
• 87: Oracle Corp. – Key customers
• 88: Oracle Corp. – Segment focus
• 89: Parexel International Corp. – Overview
• 90: Parexel International Corp. – Product and service
• 91: Parexel International Corp. – Key offerings
• 92: Parexel International Corp. – Key customers
• 93: Parexel International Corp. – Segment focus
• 94: Veeva Systems Inc. – Overview
• 95: Veeva Systems Inc. – Business segments
• 96: Veeva Systems Inc. – Key offerings
• 97: Veeva Systems Inc. – Key customers
• 98: Veeva Systems Inc. – Segment focus
• 99: Currency conversion rates for US$
• 100: Research Methodology
• 101: Validation techniques employed for market sizing
• 102: Information sources
• 103: List of abbreviations



【掲載企業】

ArisGlobal LLC, Bioclinica, Bio-Optronics Inc., Dassault Systemes SE, DATATRAK International Inc., International Business Machines Corp., Medpace Holdings Inc., Oracle Corp., Parexel International Corp., Veeva Systems Inc.

★調査レポート[臨床試験管理システム(CTMS)の世界市場2020-2024] (Global Clinical Trial Management System (CTMS) Market 2020-2024 / IRTNTR43269)販売に関する免責事項
[臨床試験管理システム(CTMS)の世界市場2020-2024] (Global Clinical Trial Management System (CTMS) Market 2020-2024 / IRTNTR43269)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆